Robeco Institutional Asset Management B.V.
Position in PCRX — Pacira BioSciences, Inc.
CIK 1418773
ROTTERDAM, P7
Position in PCRX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$4,161,035
+$588,066 QoQ
Shares Held
164,014
+3.7% QoQ
Ownership
0.411%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 253 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $403,524,623 across 13 Drug Manufacturers - Specialty & Generic names. PCRX ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
18,021,100 | $261,125,739 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
123,056 | $66,675,432 | |
| 3 | VTRS |
Viatris Inc
|
2,080,468 | $33,037,831 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
107,976 | $18,198,275 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
128,116 | $5,256,599 | |
| 6 | ALKS |
Alkermes plc.
|
92,592 | $4,851,357 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
174,003 | $4,282,213 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
This page
|
164,014 | $4,161,035 |
All Filings in PCRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,161,035 | 164,014 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $3,572,969 | 158,096 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $1,397,649 | 54,005 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $1,391,708 | 54,005 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $1,290,719 | 54,005 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $2,054,945 | 82,694 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $1,317,744 | 69,944 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $1,052,657 | 69,944 | Shares | Defined | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||